CN Stock MarketDetailed Quotes

603079 Zhejiang Shengda Bio-Pharm

Watchlist
  • 10.39
  • -0.15-1.42%
Market Closed Sep 13 15:00 CST
1.78BMarket Cap-57087P/E (TTM)

Zhejiang Shengda Bio-Pharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
5.91%384.47M
9.19%184.83M
-1.44%727.41M
1.53%544.11M
3.59%363.03M
-8.58%169.28M
-6.55%738.02M
-7.56%535.91M
-10.17%350.44M
-3.52%185.17M
Operating revenue
5.91%384.47M
9.19%184.83M
-1.44%727.41M
1.53%544.11M
3.59%363.03M
-8.58%169.28M
-6.55%738.02M
-7.56%535.91M
-10.17%350.44M
-3.52%185.17M
Other operating revenue
-53.47%476.6K
----
82.81%1.94M
----
10.67%1.02M
----
-13.42%1.06M
----
41.46%925.62K
----
Total operating cost
0.97%364.48M
5.56%177.35M
3.00%729.02M
8.15%540.12M
12.91%360.97M
0.48%168.01M
-3.13%707.79M
-4.83%499.43M
-9.14%319.7M
-0.84%167.21M
Operating cost
2.52%307.57M
7.39%147.71M
0.62%610.95M
8.92%448.56M
15.37%300M
2.26%137.55M
8.18%607.17M
0.14%411.83M
-6.28%260.04M
-2.42%134.51M
Operating tax surcharges
14.94%4.78M
50.18%2.25M
9.11%9.41M
19.40%6.83M
23.64%4.16M
-32.00%1.5M
-21.69%8.63M
-9.79%5.72M
-11.95%3.36M
17.75%2.2M
Operating expense
-2.40%6.48M
-7.39%2.77M
7.19%14.2M
-5.55%9.7M
2.54%6.64M
5.73%2.99M
6.24%13.25M
44.44%10.27M
49.17%6.48M
122.79%2.83M
Administration expense
-9.58%32.22M
1.43%17.75M
-1.96%61.96M
-19.88%53.34M
-13.90%35.63M
-1.23%17.5M
-35.11%63.2M
-2.23%66.58M
-0.59%41.39M
-16.61%17.72M
Financial expense
19.49%-5.38M
-42.32%-1.03M
52.31%-10.44M
63.36%-8.5M
41.57%-6.68M
-126.25%-721.61K
-346.76%-21.88M
-688.39%-23.19M
-325.55%-11.43M
247.70%2.75M
-Interest expense (Financial expense)
105.03%848.17K
279.23%573.62K
-66.28%1.54M
-79.46%948.16K
-85.45%413.68K
-91.28%151.26K
-20.84%4.56M
6.87%4.62M
-7.48%2.84M
52.66%1.73M
-Interest Income (Financial expense)
9.69%-3.18M
38.06%-1.27M
-110.92%-8.41M
-41.82%-5.33M
-335.97%-3.52M
-411.12%-2.05M
-35.83%-3.99M
11.65%-3.76M
69.55%-807.53K
74.73%-401.85K
Research and development
-11.35%18.81M
-14.09%7.9M
14.72%42.92M
6.96%30.19M
6.81%21.22M
27.74%9.19M
-5.61%37.42M
0.65%28.22M
1.72%19.86M
-12.68%7.2M
Credit Impairment Loss
-154.83%-4.3M
-182.25%-856.53K
-592.56%-3.16M
-608.89%-1.12M
-199.50%-1.69M
80.66%-303.46K
49.07%-456.39K
88.71%-158.09K
56.24%-562.81K
-54.76%-1.57M
Asset Impairment Loss
-12.11%-5.91M
---2.71M
-182.91%-50.81M
23.27%-4.83M
-2.53%-5.27M
----
-174.38%-17.96M
17.26%-6.3M
-23.72%-5.14M
92.83%-150.7K
Other net revenue
-119.33%-2.64M
-99.43%26.38K
-844.91%-44.06M
-87.43%2.15M
-108.04%-1.2M
-17.25%4.61M
-73.57%5.92M
18.89%17.14M
27.99%14.97M
302.85%5.57M
Fair value change income
-93.67%1.11K
----
100.01%100.88
300.18%28.84K
221.61%17.52K
----
-6,325.82%-897.06K
95.82%-14.41K
97.34%-14.41K
---14.41K
Invest income
332.62%2.93M
149.72%1.69M
-96.40%406.51K
-93.12%735.39K
-93.55%677.25K
-69.26%677.25K
-47.58%11.29M
-33.38%10.69M
-9.89%10.5M
2,164.20%2.2M
Asset deal income
----
----
132.20%202.17K
206.32%301.71K
252.88%301.71K
----
6,489.49%87.07K
7,354.35%98.5K
--85.5K
--85.5K
Other revenue
-2.58%4.64M
-55.11%1.9M
-32.87%9.3M
-45.08%7.04M
-52.92%4.76M
-15.55%4.24M
67.44%13.85M
65.92%12.82M
67.62%10.11M
13.95%5.02M
Operating profit
1,935.37%17.35M
27.70%7.51M
-226.35%-45.68M
-88.55%6.14M
-98.14%852.5K
-75.02%5.88M
-55.61%36.15M
-22.68%53.62M
-8.55%45.71M
-4.71%23.53M
Add:Non operating Income
3,569.41%11.02M
-85.91%65.9K
213.65%2.99M
-17.66%635.2K
-40.69%300.23K
218.73%467.68K
93.14%953.47K
65.50%771.43K
75.11%506.19K
-40.63%146.73K
Less:Non operating expense
280.12%4.18M
-99.65%2.66K
353.26%2.62M
336.05%1.71M
327.45%1.1M
54,783.87%769.57K
-69.49%578.54K
-84.52%392.99K
322.30%256.96K
-97.66%1.4K
Total profit
44,395.29%24.19M
35.75%7.57M
-224.05%-45.31M
-90.63%5.06M
-99.88%54.37K
-76.45%5.58M
-54.37%36.52M
-19.74%54M
-8.47%45.96M
-4.84%23.68M
Less:Income tax cost
-22.76%4.71M
-1.69%2.26M
46.16%8.89M
-15.02%7.69M
-10.27%6.1M
-29.79%2.3M
-25.97%6.09M
19.76%9.05M
48.37%6.8M
16.42%3.28M
Net profit
FLtoP19.48M
62.12%5.3M
SL-54.2M
SL-2.63M
SL-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
-7.56%20.4M
Net profit from continuing operation
421.96%19.48M
62.12%5.3M
-278.07%-54.2M
-105.84%-2.63M
-115.45%-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
-7.56%20.4M
Less:Minority Profit
953.65%2.98M
779.46%1.49M
86.73%-138.76K
201.45%1.06M
136.72%283.15K
45.72%-219.41K
73.43%-1.05M
75.39%-1.05M
65.87%-771.17K
69.50%-404.2K
Net profit of parent company owners
360.46%16.49M
9.22%3.81M
-271.71%-54.06M
-108.02%-3.69M
-115.86%-6.33M
-83.22%3.49M
-58.44%31.48M
-28.10%45.99M
-16.62%39.93M
-11.07%20.8M
Earning per share
Basic earning per share
350.00%0.1
0.00%0.02
-277.78%-0.32
-107.41%-0.02
-117.39%-0.04
-83.33%0.02
-59.09%0.18
-27.03%0.27
-17.86%0.23
-14.29%0.12
Diluted earning per share
350.00%0.1
0.00%0.02
-277.78%-0.32
-107.41%-0.02
-117.39%-0.04
-83.33%0.02
-59.09%0.18
-27.03%0.27
-17.86%0.23
-14.29%0.12
Other composite income
Total composite income
421.96%19.48M
62.12%5.3M
-278.07%-54.2M
-105.84%-2.63M
-115.45%-6.05M
-83.96%3.27M
-57.62%30.44M
-24.74%44.95M
-14.18%39.16M
-7.56%20.4M
Total composite income of parent company owners
360.46%16.49M
9.22%3.81M
-271.71%-54.06M
-108.02%-3.69M
-115.86%-6.33M
-83.22%3.49M
-58.44%31.48M
-28.10%45.99M
-16.62%39.93M
-11.07%20.8M
Total composite income of minority owners
953.65%2.98M
779.46%1.49M
86.73%-138.76K
201.45%1.06M
136.72%283.15K
45.72%-219.41K
73.43%-1.05M
75.39%-1.05M
65.87%-771.17K
69.50%-404.2K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 5.91%384.47M9.19%184.83M-1.44%727.41M1.53%544.11M3.59%363.03M-8.58%169.28M-6.55%738.02M-7.56%535.91M-10.17%350.44M-3.52%185.17M
Operating revenue 5.91%384.47M9.19%184.83M-1.44%727.41M1.53%544.11M3.59%363.03M-8.58%169.28M-6.55%738.02M-7.56%535.91M-10.17%350.44M-3.52%185.17M
Other operating revenue -53.47%476.6K----82.81%1.94M----10.67%1.02M-----13.42%1.06M----41.46%925.62K----
Total operating cost 0.97%364.48M5.56%177.35M3.00%729.02M8.15%540.12M12.91%360.97M0.48%168.01M-3.13%707.79M-4.83%499.43M-9.14%319.7M-0.84%167.21M
Operating cost 2.52%307.57M7.39%147.71M0.62%610.95M8.92%448.56M15.37%300M2.26%137.55M8.18%607.17M0.14%411.83M-6.28%260.04M-2.42%134.51M
Operating tax surcharges 14.94%4.78M50.18%2.25M9.11%9.41M19.40%6.83M23.64%4.16M-32.00%1.5M-21.69%8.63M-9.79%5.72M-11.95%3.36M17.75%2.2M
Operating expense -2.40%6.48M-7.39%2.77M7.19%14.2M-5.55%9.7M2.54%6.64M5.73%2.99M6.24%13.25M44.44%10.27M49.17%6.48M122.79%2.83M
Administration expense -9.58%32.22M1.43%17.75M-1.96%61.96M-19.88%53.34M-13.90%35.63M-1.23%17.5M-35.11%63.2M-2.23%66.58M-0.59%41.39M-16.61%17.72M
Financial expense 19.49%-5.38M-42.32%-1.03M52.31%-10.44M63.36%-8.5M41.57%-6.68M-126.25%-721.61K-346.76%-21.88M-688.39%-23.19M-325.55%-11.43M247.70%2.75M
-Interest expense (Financial expense) 105.03%848.17K279.23%573.62K-66.28%1.54M-79.46%948.16K-85.45%413.68K-91.28%151.26K-20.84%4.56M6.87%4.62M-7.48%2.84M52.66%1.73M
-Interest Income (Financial expense) 9.69%-3.18M38.06%-1.27M-110.92%-8.41M-41.82%-5.33M-335.97%-3.52M-411.12%-2.05M-35.83%-3.99M11.65%-3.76M69.55%-807.53K74.73%-401.85K
Research and development -11.35%18.81M-14.09%7.9M14.72%42.92M6.96%30.19M6.81%21.22M27.74%9.19M-5.61%37.42M0.65%28.22M1.72%19.86M-12.68%7.2M
Credit Impairment Loss -154.83%-4.3M-182.25%-856.53K-592.56%-3.16M-608.89%-1.12M-199.50%-1.69M80.66%-303.46K49.07%-456.39K88.71%-158.09K56.24%-562.81K-54.76%-1.57M
Asset Impairment Loss -12.11%-5.91M---2.71M-182.91%-50.81M23.27%-4.83M-2.53%-5.27M-----174.38%-17.96M17.26%-6.3M-23.72%-5.14M92.83%-150.7K
Other net revenue -119.33%-2.64M-99.43%26.38K-844.91%-44.06M-87.43%2.15M-108.04%-1.2M-17.25%4.61M-73.57%5.92M18.89%17.14M27.99%14.97M302.85%5.57M
Fair value change income -93.67%1.11K----100.01%100.88300.18%28.84K221.61%17.52K-----6,325.82%-897.06K95.82%-14.41K97.34%-14.41K---14.41K
Invest income 332.62%2.93M149.72%1.69M-96.40%406.51K-93.12%735.39K-93.55%677.25K-69.26%677.25K-47.58%11.29M-33.38%10.69M-9.89%10.5M2,164.20%2.2M
Asset deal income --------132.20%202.17K206.32%301.71K252.88%301.71K----6,489.49%87.07K7,354.35%98.5K--85.5K--85.5K
Other revenue -2.58%4.64M-55.11%1.9M-32.87%9.3M-45.08%7.04M-52.92%4.76M-15.55%4.24M67.44%13.85M65.92%12.82M67.62%10.11M13.95%5.02M
Operating profit 1,935.37%17.35M27.70%7.51M-226.35%-45.68M-88.55%6.14M-98.14%852.5K-75.02%5.88M-55.61%36.15M-22.68%53.62M-8.55%45.71M-4.71%23.53M
Add:Non operating Income 3,569.41%11.02M-85.91%65.9K213.65%2.99M-17.66%635.2K-40.69%300.23K218.73%467.68K93.14%953.47K65.50%771.43K75.11%506.19K-40.63%146.73K
Less:Non operating expense 280.12%4.18M-99.65%2.66K353.26%2.62M336.05%1.71M327.45%1.1M54,783.87%769.57K-69.49%578.54K-84.52%392.99K322.30%256.96K-97.66%1.4K
Total profit 44,395.29%24.19M35.75%7.57M-224.05%-45.31M-90.63%5.06M-99.88%54.37K-76.45%5.58M-54.37%36.52M-19.74%54M-8.47%45.96M-4.84%23.68M
Less:Income tax cost -22.76%4.71M-1.69%2.26M46.16%8.89M-15.02%7.69M-10.27%6.1M-29.79%2.3M-25.97%6.09M19.76%9.05M48.37%6.8M16.42%3.28M
Net profit FLtoP19.48M62.12%5.3MSL-54.2MSL-2.63MSL-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M-7.56%20.4M
Net profit from continuing operation 421.96%19.48M62.12%5.3M-278.07%-54.2M-105.84%-2.63M-115.45%-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M-7.56%20.4M
Less:Minority Profit 953.65%2.98M779.46%1.49M86.73%-138.76K201.45%1.06M136.72%283.15K45.72%-219.41K73.43%-1.05M75.39%-1.05M65.87%-771.17K69.50%-404.2K
Net profit of parent company owners 360.46%16.49M9.22%3.81M-271.71%-54.06M-108.02%-3.69M-115.86%-6.33M-83.22%3.49M-58.44%31.48M-28.10%45.99M-16.62%39.93M-11.07%20.8M
Earning per share
Basic earning per share 350.00%0.10.00%0.02-277.78%-0.32-107.41%-0.02-117.39%-0.04-83.33%0.02-59.09%0.18-27.03%0.27-17.86%0.23-14.29%0.12
Diluted earning per share 350.00%0.10.00%0.02-277.78%-0.32-107.41%-0.02-117.39%-0.04-83.33%0.02-59.09%0.18-27.03%0.27-17.86%0.23-14.29%0.12
Other composite income
Total composite income 421.96%19.48M62.12%5.3M-278.07%-54.2M-105.84%-2.63M-115.45%-6.05M-83.96%3.27M-57.62%30.44M-24.74%44.95M-14.18%39.16M-7.56%20.4M
Total composite income of parent company owners 360.46%16.49M9.22%3.81M-271.71%-54.06M-108.02%-3.69M-115.86%-6.33M-83.22%3.49M-58.44%31.48M-28.10%45.99M-16.62%39.93M-11.07%20.8M
Total composite income of minority owners 953.65%2.98M779.46%1.49M86.73%-138.76K201.45%1.06M136.72%283.15K45.72%-219.41K73.43%-1.05M75.39%-1.05M65.87%-771.17K69.50%-404.2K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data